×
Home Companies Industry Politics Money Opinion LoungeMultimedia Science Education Sports TechnologyConsumerSpecialsMint on Sunday
×

Glenmark’s pain drug enters clinical trials

Glenmark’s pain drug enters clinical trials
Comment E-mail Print Share
First Published: Fri, Jan 23 2009. 03 22 PM IST
Updated: Fri, Jan 23 2009. 03 22 PM IST
Mumbai: Glenmark Pharmaceuticals Ltd on Friday said its experimental molecule for pain treatment has entered initial stage of clinical trials.
Glenmark, which has filed with UK’s Medicines and Healthcare Products Regulatory Agency, expects to complete the trials by end 2009 on the molecule GRC 15300, the company said in a statement.
The molecule is being developed to treat neuropathic pain, osteoarthritic pain and other inflammatory conditions.
Comment E-mail Print Share
First Published: Fri, Jan 23 2009. 03 22 PM IST